Vertex Pharmaceuticals Incorporated (VRTX) earnings: date, estimates, results and stock reactions
Next earnings: Q1 FY2027 on 2027-02-11 (expected, time not announced). EPS estimate 4.20, revenue estimate 3.50B.
Over the last 12 reports the stock moved 4.6% on average (either way), rising 5 times and falling 7. EPS beat estimates 6 of 12 times; revenue 9 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q4 FY2026 | 2026-11-02 | 4.76 | 4.82 | -1.2% | 3.44B | 3.42B | -5.0% |
| Q3 FY2026 | 2026-08-03 | 4.73 | 4.74 | -0.2% | 3.33B | 3.23B | +0.3% |
| Q2 FY2026 | 2026-05-04 | 4.47 | 4.24 | +5.4% | 2.99B | 2.99B | +0.1% |
| Q1 FY2026 | 2026-02-12 | 5.03 | 5.11 | -1.6% | 3.19B | 3.18B | +6.6% |
| Q4 FY2025 | 2025-11-03 | 4.80 | 4.57 | +5.0% | 3.08B | 3.06B | -0.9% |
| Q3 FY2025 | 2025-08-04 | 4.52 | 4.29 | +5.4% | 2.96B | 2.91B | -18.9% |
| Q2 FY2025 | 2025-05-05 | 4.06 | 4.25 | -4.5% | 2.77B | 2.86B | -10.2% |
| Q1 FY2025 | 2025-02-10 | 3.98 | 4.02 | -1.0% | 2.91B | 2.78B | -3.0% |